Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,162.79, giving the company a market capitalization of 1.09T. It carries a P/E multiple of 39.42 and pays a dividend yield of 0.58%.
On 2026-09-02, Eli Lilly(LLY) stock traded between a low of $1,158.65 and a high of $1,187.83. Shares are currently priced at $1,162.79, which is +0.4% above the low and -2.1% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.17M, compared to an average daily volume of 2.72M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
...
J.P. Morgan analyst Chris Schott maintained a Buy rating on Eli Lilly & Co today and set a price target of $1,400.00. Chris Schott has given his Buy rating due...
Eli Lilly stock has delivered very strong gains over the past five years, yet current valuation checks still point to a meaningful gap between the share price a...
Analyst ratings
82%
of 33 ratingsMore LLY News
Key Points The results of a study Eli Lilly ran suggest that patients older than 55 on Zepbound incur lower healthcare costs than those not on Zepbound. This...
Eli Lilly LLY announced that it has entered into a definitive agreement to acquire clinical-stage biotech Merida Biosciences in an all-cash transaction for up t...
Investing Insurers Are Pulling Back From GLP-1 Drugs. The FDA Just Handed Eli Lilly Its Best Weapon Yet Employer coverage of GLP-1 drugs is collapsing heading i...
Investing Jim Cramer: This Little-Talked-About Drug Could Target the “Biggest Market of All Time” Aside From Eli Lilly’s GLP-1 Drugs Jim Cramer is flagging an A...
Eli Lilly (NYSE: LLY) plans to acquire Merida Biosciences to expand its autoimmune and allergic disease pipeline, including lead candidate MER511. The deal is...
Key Points It has agreed to pay up to nearly $2.88 billion for a clinical-stage biotech. That company's uniqueness was a clear attraction for the pharmaceutic...
Eli Lilly (LLY) is acquiring privately held Merida Biosciences for $2.88 billion in cash, as it looks to grow its treatments for autoimmune diseases and allerg...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.